argenx SE | Spese Operative



Operating Expenses Cambiamento Data
AstraZeneca USD 12.86B 2.06B 2024-12
Galapagos EUR 138.22M 24.07M 2024-12
Genmab DKK 4.25B 812M 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
GRIFOLS EUR 1.6B 128.03M 2024-12
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Qiagen NV USD 377.04M 4.6M 2024-12
UCB EUR 1.23B 1.31B 2024-06



argenx SE Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.